|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-11-2
|
|
pubmed:abstractText |
To investigate the time to progression (TTP) and overall survival in patients with previously untreated metastatic or relapsed esophageal squamous cell carcinoma treated with chemotherapy (paclitaxel plus cisplatin) combined with radiotherapy versus chemotherapy alone, and also to evaluate the efficacy and toxicity of the regimen.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0253-3766
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
474-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17974288-Adolescent,
pubmed-meshheading:17974288-Adult,
pubmed-meshheading:17974288-Aged,
pubmed-meshheading:17974288-Alopecia,
pubmed-meshheading:17974288-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17974288-Carcinoma, Squamous Cell,
pubmed-meshheading:17974288-Cisplatin,
pubmed-meshheading:17974288-Combined Modality Therapy,
pubmed-meshheading:17974288-Esophageal Neoplasms,
pubmed-meshheading:17974288-Fatigue,
pubmed-meshheading:17974288-Follow-Up Studies,
pubmed-meshheading:17974288-Humans,
pubmed-meshheading:17974288-Liver Neoplasms,
pubmed-meshheading:17974288-Lung Neoplasms,
pubmed-meshheading:17974288-Lymphatic Metastasis,
pubmed-meshheading:17974288-Middle Aged,
pubmed-meshheading:17974288-Neoplasm Recurrence, Local,
pubmed-meshheading:17974288-Neoplasm Staging,
pubmed-meshheading:17974288-Neutropenia,
pubmed-meshheading:17974288-Paclitaxel,
pubmed-meshheading:17974288-Prospective Studies,
pubmed-meshheading:17974288-Radiotherapy,
pubmed-meshheading:17974288-Radiotherapy, High-Energy,
pubmed-meshheading:17974288-Survival Analysis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
|
|
pubmed:affiliation |
Department of Gastrointestinal Medicine, Clinical Cancer Institute, Beijing Cancer Hospital, Peking University, Beijing 100036, China. zxdbj@vip.sina.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract
|
